An observational study in Mindfulness and Borderline Personality Disorder, sponsored by Katharina Bachmann. Status unknown at 1 site in Germany. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2017-09-29.
Sponsored by Katharina Bachmann · Observational
Among 37 studies in Borderline Personality Disorder with a site in Germany — 6 open to participants now, 7 under way, none of them phase 3. Borderline Personality Disorder · Germany.
Among the 37 studies in Borderline Personality Disorder with a site in Germany, this one is one of 2 that started in 2017, is one of 9 observational ones, and was the 13th registered.
278 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.
Browse Borderline Personality Disorder studies →6 of the 37 studies in Borderline Personality Disorder with a site in Germany are open now. Recruiting first, the newest first:
University Hospital Heidelberg · Sites in Germany
Ages 18–65
Central Institute of Mental Health, Mannheim · Sites in Germany
Ages 18–65
Heidelberg University · Sites in Germany
Ages 18–65
Heidelberg University · Sites in Germany
Ages 18+ · Healthy volunteers
University Hospital, Bonn · Sites in Germany
Ages 18–50 · Healthy volunteers
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 49 Borderline Personality Disorder studies recruiting now, 18 (37%) set no upper age limit and 30 (61%) stop at 75 or younger; 8 take children under 18; 11 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 2
First in 1998; this study’s year is marked. 2 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 91 across 44 observational studies indexed under Borderline Personality Disorder.
Median enrollment 120 across the 28 interventional studies, 60 across the 9 observational. Of the 26 that completed or were terminated, 4 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 37 have an industry lead sponsor. The 10 most frequent:
Katharina Bachmann is the lead sponsor of 2 studies on the registry; none are open to participants now.
Katharina Bachmann has 2 studies filed under Borderline Personality Disorder — fewer than ten, so there is no comparison to draw.
2 of the studies in Borderline Personality Disorder with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07639957University Hospital HeidelbergThe Role of Gender in Borderline Personality Disorder | 2026-12-31 |
| NCT06018272Heidelberg UniversityMentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 37 studies in Borderline Personality Disorder with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.
Participants will be recruited from the Dialectical-Behavioral-Therapy (DBT) unit. DBT is a treatment approach that has been shown to be effective in the treatment of Borderline Personality Disorder. DBT integrates different psychotherapeutic interventions as well as Mindfulness Meditation exercises. Mindfulness is a meditation practice that can improve present moment awareness. When applied as therapeutic intervention mindfulness meditation can help patients to stay with their attention in the present moment, to be aware what is happening in the here and now, and to better identify and regulate upcoming emotions.
The current observational study investigates changes in symptom severity and mindfulness skills during DBT treatment. A treatment group will be compared to a waitlist control group. The two groups are predefined by routine medical care.
Symptom severity and mindfulness skills will be assessed at baseline (before treatment or when accepted for the waitlist) and after 12-weeks. A within and between group analyses will be performed.
Male and female BPD Patients from 18 to 60 years.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with Borderline Personality Disorder receiving DBT treatment. Measurement takes place at the beginning of the treatment and a second time after 12-weeks treatment.
Behavioral: Dialectical Behavioural Therapy (DBT)
Patients with Borderline Personality Disorder on the waitlist for inpatient DBT treatment. Measurement takes place twice at baseline and after 12-weeks waiting.
Inpatient Dialectical Behavioural Therapy (DBT) according to Linehan.
Change in mindfulness
Degree of mindfulness will be assessed by the Kentucky Inventory of Mindfulness Skills, German Version (KIMS-D). A within and between group comparison will be performed (treatment vs. waitlist).
Time frame: Baseline and after 12-weeks
Change in borderline symptom severity
Change in Borderline symptom severity is measured by the Borderline Symptom List (BSL 23). A within and between group comparison will be performed (treatment vs. waitlist).
Time frame: Baseline and after 12-weeks
Change in overall psychiatric symptom severity
Change in overall symptom severity is measured by the Change in symptomseverity is measured by the Symptom-Checklist-90®-Standard (SCL-90). A within and between group comparison will be performed (treatment vs. waitlist).
Time frame: Baseline and after 12-weeks
Change in severity in symptoms of depression
Change in overall symptom severity is measured by the Beck depression inventory (BDI). A within and between group comparison will be performed (treatment vs. waitlist).
Time frame: Baseline and after 12-weeks
Plan to share: Undecided
Started May 2017 (actual). Primary completion is estimated for Nov 2017, 6 months after the start.
Of 19 observational studies under Borderline Personality Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 119. This study's planned 6 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Borderline Personality Disorder →
Katharina Bachmann